| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
35,784 |
32,436 |
$1.39M |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
25,079 |
22,912 |
$1.04M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
11,952 |
11,604 |
$817K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
36,820 |
17,351 |
$521K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,131 |
8,612 |
$518K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
14,699 |
13,985 |
$206K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
5,613 |
4,921 |
$152K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
3,045 |
2,925 |
$131K |
| 87428 |
|
1,913 |
1,820 |
$81K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,542 |
2,259 |
$61K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,368 |
2,710 |
$50K |
| 87807 |
|
1,491 |
1,400 |
$17K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
91 |
90 |
$7K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
171 |
158 |
$4K |
| 81002 |
|
3,727 |
3,559 |
$3K |
| 81025 |
|
303 |
297 |
$2K |
| 95117 |
|
152 |
61 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
782 |
744 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
79 |
75 |
$1K |
| 90658 |
|
77 |
74 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
120 |
72 |
$917.18 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
103 |
94 |
$869.52 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
15 |
15 |
$798.30 |
| 73120 |
|
14 |
12 |
$221.65 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
20 |
19 |
$149.47 |
| A7006 |
Administration set, with small volume filtered pneumatic nebulizer |
32 |
30 |
$140.80 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
75 |
66 |
$99.24 |
| 82947 |
|
12 |
12 |
$49.01 |
| 81003 |
|
131 |
127 |
$24.21 |
| 99000 |
|
19 |
17 |
$0.00 |